Monday - December 23, 2024

Inhibitors of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) and Methods of Use Thereof

2024-11-26

ALEXANDRIA, Virginia, Nov. 26 -- STINGRAY THERAPEUTICS, INC., Houston, Texas has been assigned a patent (No. US 12152015 B2, initially filed Feb. 14, 2023) developed by six inventors Srinivas Rao Kasibhatla, San Diego, California; Raman Kumar Kalakuntla, Telangana, India; Alexis Weston, Phoenix, Arizona; Trason Thode, Phoenix, Arizona; Sunil Sharma, Phoenix, Arizona; and Mohan R. Kaadige, Scottsdale, Arizona, for "Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and meth . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Inhibitors of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) and Methods of Use Thereof

Information Request Form

Copyright Targeted News Service 2024